Chemotherapy of bacterial infections. Part II.. Antibiotics – after-effects:

Slides:



Advertisements
Similar presentations
Mechanisms of Genetic Variation 1 16 Copyright © McGraw-Hill Global Education Holdings, LLC. Permission required for reproduction or display.
Advertisements

Bacterial Drug Resistance Discovery of penicillin –Sir Alexander Fleming. –Accidental mold contamination. Chinese, Egyptians, Europeans used moldy.
Dr.T.V.Rao MD CLINDAMYCIN USES AND CONCERNS DR.T.V.RAO MD 1.
Control of Microbial Growth Tim Ho University of Alberta, Canada * The materials are mostly based on Dr. Brian Lanoil’s Microb Part.
The Increasing Public Health Exigency of Antimicrobial Resistance Alfred DeMaria, Jr., M.D. Massachusetts Department of Public Health.
Antimicrobial Susceptibility Testing – Part II
Streptococci Vs Ery 5/Da 2 Multiple mechanisms of resistance Macrolides (eryth., clarith., roxith.) Lincosamides (clindamycin, lincomycin) 1.Ribosomal.
Lecture 4 Vancomycin resistance VRE VISA / hVISA / VRSA Thursday – 1/17/2008.
Antimicrobials 3: Resistance Dr Fiona Walsh. Objectives of lecture Genetics of resistance Mechanisms of resistance Current and future problems.
1 Antimicrobial Therapy Chemotherapy: any treatment of patient with chemicals to treat a condition. –Now word associated with cancer treatment –Our focus.
Antibiotics Biotechnology II. Univ S. Carolina Antibiotics Disrupt Cell Wall Synthesis, Protein Synthesis, Nucleic Acid Synthesis and Metabolism.
CHAPTER 20 ANTIBIOTIC RESISTANCE
Antimicrobial Medications
Clindamycin induction test in treating patients infected with methicilin resistant Staphylococcus aureus Presented by Iyad Kaddora.
Mechanisms of antimicrobial action directed against the bacterial cell wall and corresponding resistance mechanisms M-4 Advanced Therapeutics Course.
Nocosomial infection with Vancomycin-dependent Enterococci Michelle Nguyen Bioc /11/04.
Microbiology Antimicrobial Susceptibility Testing – Part I Karen Honeycutt, M.Ed., MT(ASCP)SM CLS 418 Clinical Microbiology Student Laboratory Session.
MECHANISMS OF ANTIBIOTIC RESISTANCE Dr T. Aswani Ndonga Msc TID I April 2010.
Antimicrobial compounds Antiseptics and disinfectants Antibiotics.
“Emerging infections, the re-emergence of infectious diseases previously considered to be under control, and the alarming trend of antibiotic resistance….require.
FQ Resistance vs FQ Use Development of Antibiotic Resistance.
Chemical Control Methods
BACTERIAL RESISTANCE TO ANTIBIOTICS 1. 2 Drug Resistance: A condition in which there is insensitivity or decreased sensitivity to drugs that ordinarily.
Antibiotic Resistance The Miracle Revoked? Wilson “Bill” Muse 10/29/2009.
PHL 424 Antimicrobials 5 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Batterjee Medical College. Dr. Manal El Said Department Head of Microbiology Antimicrobial Drugs: Mechanism of Action.
Antibiotic Resistance in Microbes A few microbes to be concerned about How some antibiotics and Antimicrobials work Resistance mechanisms Some factors.
ANTIMICROBIAL AGENTS. ANTIBIOTICS ANTIMICROBIAL AGENTS CHEMOTHERAPEUTIC AGENTS.
Antimicrobial Drugs.
1 ANTIMICROBIAL THERAPY CHAPTER Chemotherapeutic Agents Antibiotics: bacteriocidal vs bacteriostatic Synthetic Drugs vs natural product.
Do we need and can we find novel antibiotics from microorganisms? ISBA 17 Joachim Wink PD Dr. Joachim Wink Frankfurt, August 2015.
Antibiotic Resistance
Conjugative DNA transfer, antibiotic resistance and MDR bacteria With thanks to Steve Matson Who first created this lecture.
THINGS TO BE DISCUSSED Multi resistance antimicrobials Effects of some Antibiotics Research article Case study Future Horizons.
Supplemental testing methods
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Bacterial Genetics. Vocabulary Binary fission Exponential growth Gram positive Gram negative Pathogen Antibiotic Selection pressure Adaptation Mutation.
Copyright (c) 2004 Elsevier Inc. All rights reserved. Basic Principles of Antimicrobial Therapy Chapter 79.
PRINCIPLES OF ANTIBIOTIC THERAPY
IMPORTANT ANTIBIOTICS AND ANTIMICROBIAL RESISTANCE A Presentation By Ms R.Venkatajothi, MSc., MPhil, PhD Senior Lecturer Department of Microbiology Faculty.
Chapter 8, part B Microbial Genetics.
Chapter 8, part B Microbial Genetics.
ANTIMICROBIAL AGENTS.
Bacterial Targets for Antimicrobial Therapy
Antibiotic Resistance
Antibiotic Resistance
Lecture 1 Antimicrobial drugs.
Intro to Antibiotics By: Alaina Darby.
General considerations of antimicrobial agents (抗微生物药物概论)
Medical Microbiology Chapter 24 Enterococcus.
by Dr.Sawsan Sajid & Dr. Ibtesam G.Auda
Molecular Mechanisms of Antibacterial Multidrug Resistance
Chapter 20 Antibacterial Agents
Antimicrobial Medications
Chemotherapeutic agent
Antibiotic Resistance
Chemotherapeutic Medicine
A. Fajardo, J.F. Linares, J.L. Martínez 
Emergence of vancomycin-resistant enterococci in a tertiary hospital in Crete, Greece: a cluster of cases and prevalence study on intestinal colonisation 
Streptococci Vs Ery 5/Da 2
Mechanisms of Resistance and Clinical Relevance of Resistance to β-Lactams, Glycopeptides, and Fluoroquinolones  Louis B. Rice, MD  Mayo Clinic Proceedings 
The dynamic relationship between antibiotic use and the incidence of vancomycin- resistant Enterococcus: time-series modelling of 7-year surveillance data.
Sohyun Cho (Gabi) Frye Lab
Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium  K. Hegstad,
Investigate the Treatment of Infectious Diseases
… genetics will someday make BRD as we know it a distant memory
Chapter 8, part B Microbial Genetics.
Antimicrobial resistance
Introduction to Microbiology
Presentation transcript:

Chemotherapy of bacterial infections. Part II.

Antibiotics – after-effects:

Origin of drug resistance: intrinsic - inherent, natural acquired nongenetic -lack of active replication -loss of the specific target structure (L-forms) -infection ocurring at sites where antimicrobials are excluded or not active

genetic - chromosomal resistance: mutation  resistant mutants selection o stable o allow vertical transmission of resistance only (descending) o allow no horizontal transmission: not transferable from one bacterium to another o these genes cause intrinsic resistance

Macrolide-Lincosamide- Streptogramin Resistance The MLS group: macrolides, lincosamides and streptogramins (A and B); resistance - due to efflux, target modification, drug enzymatic modification. In staphs, erythromycin resistance is caused by the erm gene coding an enzyme which modifies the ribosome NONE of these antibiotics may bind to the ribosome. If the erm gene product is constitutively produced, testing will find the staph resistant to all of the MLS antibiotics. If the erm gene product is inducibly produced, it will only be expressed when the organism is exposed to a macrolide C 14 and C 15, but not C 16 and ketolides.

Acquired Resistance to Aminoglycosides mainly enzymatic drug modification Kan HC Gen HC - HLAR E. faecalis IntermediateIntermediateSynergy with B-lactam and Kan or Gen ResistantResistantNo synergy with B- lactam and Kan or Gen ResistantIntermediateNo synergy with B- lactam and Kan

Glycopeptide resistance GISA, VISA glycopeptide, vancomycin intermediate susceptible Staphylococcus aureus Enterococci have natural susceptibility to vancomycin, except E. casseliflavus and E. galinarum (natural resistance to vancomycin).vanAvanBvanC  vanA confers high level resistance to vancomycin  vanB confers moderate level resistance to vancomycin  vanC causes intrinsic vancomycin resistance in E. gallinarum and E. casseliflavus VRE (Vancomycin Resistant Enterococci) refers to E.fecalis or E.faecium, which are normally sensitive to vancomycin. Vancomycin resistance in these organisms is due to the acquisition of vanA or vanB.